Frontiers in Immunology (Oct 2024)
A distinct immune landscape in anti-synthetase syndrome profiled by a single-cell genomic study
- Jiayu Ding,
- Jiayu Ding,
- Jiayu Ding,
- Jiayu Ding,
- Yanmei Li,
- Yanmei Li,
- Zhiqin Wang,
- Zhiqin Wang,
- Zhiqin Wang,
- Zhiqin Wang,
- Feng Han,
- Feng Han,
- Ming Chen,
- Ming Chen,
- Jun Du,
- Jun Du,
- Tong Yang,
- Tong Yang,
- Mei Zhang,
- Mei Zhang,
- Yingai Wang,
- Yingai Wang,
- Jing Xu,
- Gaoya Wang,
- Gaoya Wang,
- Yong Xu,
- Yong Xu,
- Xiuhua Wu,
- Xiuhua Wu,
- Jian Hao,
- Jian Hao,
- Xinlei Liu,
- Xinlei Liu,
- Guangxin Zhang,
- Na Zhang,
- Na Zhang,
- Wenwen Sun,
- Wenwen Sun,
- Zhigang Cai,
- Zhigang Cai,
- Zhigang Cai,
- Zhigang Cai,
- Zhigang Cai,
- Wei Wei,
- Wei Wei
Affiliations
- Jiayu Ding
- The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Department of Pharmacology, School of Basic Medical Science, Tianjin Medical University, Tianjin, China
- Jiayu Ding
- National Key Laboratory of Experimental Hematology, Tianjin, China
- Jiayu Ding
- Tianjin Key Laboratory of Inflammatory Biology, Tianjin, China
- Jiayu Ding
- Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China
- Yanmei Li
- Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China
- Yanmei Li
- Tianjin Clinical Research Center for Rheumatic and Immune Diseases, Tianjin Science and Technology Bureau, Tianjin, China
- Zhiqin Wang
- The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Department of Pharmacology, School of Basic Medical Science, Tianjin Medical University, Tianjin, China
- Zhiqin Wang
- National Key Laboratory of Experimental Hematology, Tianjin, China
- Zhiqin Wang
- Tianjin Key Laboratory of Inflammatory Biology, Tianjin, China
- Zhiqin Wang
- Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China
- Feng Han
- Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China
- Feng Han
- Tianjin Clinical Research Center for Rheumatic and Immune Diseases, Tianjin Science and Technology Bureau, Tianjin, China
- Ming Chen
- Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China
- Ming Chen
- Tianjin Clinical Research Center for Rheumatic and Immune Diseases, Tianjin Science and Technology Bureau, Tianjin, China
- Jun Du
- Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China
- Jun Du
- Tianjin Clinical Research Center for Rheumatic and Immune Diseases, Tianjin Science and Technology Bureau, Tianjin, China
- Tong Yang
- Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China
- Tong Yang
- Tianjin Clinical Research Center for Rheumatic and Immune Diseases, Tianjin Science and Technology Bureau, Tianjin, China
- Mei Zhang
- Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China
- Mei Zhang
- Tianjin Clinical Research Center for Rheumatic and Immune Diseases, Tianjin Science and Technology Bureau, Tianjin, China
- Yingai Wang
- Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China
- Yingai Wang
- Tianjin Clinical Research Center for Rheumatic and Immune Diseases, Tianjin Science and Technology Bureau, Tianjin, China
- Jing Xu
- Department of Neurology, Tianjin Medical University General Hospital, Tianjin, China
- Gaoya Wang
- Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China
- Gaoya Wang
- Tianjin Clinical Research Center for Rheumatic and Immune Diseases, Tianjin Science and Technology Bureau, Tianjin, China
- Yong Xu
- Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China
- Yong Xu
- Tianjin Clinical Research Center for Rheumatic and Immune Diseases, Tianjin Science and Technology Bureau, Tianjin, China
- Xiuhua Wu
- Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China
- Xiuhua Wu
- Tianjin Clinical Research Center for Rheumatic and Immune Diseases, Tianjin Science and Technology Bureau, Tianjin, China
- Jian Hao
- Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China
- Jian Hao
- Tianjin Clinical Research Center for Rheumatic and Immune Diseases, Tianjin Science and Technology Bureau, Tianjin, China
- Xinlei Liu
- Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China
- Xinlei Liu
- Tianjin Clinical Research Center for Rheumatic and Immune Diseases, Tianjin Science and Technology Bureau, Tianjin, China
- Guangxin Zhang
- Department of Research and Development, Seekgene Biotechnology Co, Ltd, Beijing, China
- Na Zhang
- Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China
- Na Zhang
- Tianjin Clinical Research Center for Rheumatic and Immune Diseases, Tianjin Science and Technology Bureau, Tianjin, China
- Wenwen Sun
- Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China
- Wenwen Sun
- Tianjin Clinical Research Center for Rheumatic and Immune Diseases, Tianjin Science and Technology Bureau, Tianjin, China
- Zhigang Cai
- The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Department of Pharmacology, School of Basic Medical Science, Tianjin Medical University, Tianjin, China
- Zhigang Cai
- National Key Laboratory of Experimental Hematology, Tianjin, China
- Zhigang Cai
- Tianjin Key Laboratory of Inflammatory Biology, Tianjin, China
- Zhigang Cai
- Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China
- Zhigang Cai
- Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China
- Wei Wei
- Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China
- Wei Wei
- Tianjin Clinical Research Center for Rheumatic and Immune Diseases, Tianjin Science and Technology Bureau, Tianjin, China
- DOI
- https://doi.org/10.3389/fimmu.2024.1436114
- Journal volume & issue
-
Vol. 15
Abstract
ObjectivesThe objective of this study was to profile the transcriptional profiles of peripheral blood mononuclear cells (PBMCs) and their immune repertoires affected by anti-synthetase syndrome (ASS) at the single-cell level.MethodsWe performed single-cell RNA sequencing (scRNA-seq) analysis of PBMCs and bulk RNA sequencing for patients with ASS (N=3) and patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis (MDA5+ DM, N=3) along with healthy controls (HCs, N=4). As ASS and MDA5+ DM have similar organ involvements, MDA5+ DM was used as a disease control. The immune repertoire was constructed by reusing the same scRNA-seq datasets. Importantly, flow cytometry was performed to verify the results from the scRNA-seq analysis.ResultsAfter meticulous annotation of PBMCs, we noticed a significant decrease in the proportion of mucosal-associated invariant T (MAIT) cells in ASS patients compared to HCs, while there was a notable increase in the proportion of proliferative NKT cells. Compared with MDA5+ DM patients, in their PBMCs ASS patients presented substantial enrichment of interferon pathways, which were primarily mediated by IFN-II, and displayed a weak immune response. Furthermore, ASS patients exhibited more pronounced metabolic abnormalities, which may in turn affect oxidative phosphorylation pathways. Monocytes from ASS patients appear to play a crucial role as receptive signaling cells for the TNF pathway. Immunophenotyping analysis of PBMCs from ASS patients revealed an increasing trend for the clone type CQQSYSTPWTF.ConclusionUsing single-cell genomic datasets of ASS PBMCs, we revealed a distinctive profile in the immune system of individuals with ASS, compared to that with MDA5+ DM or healthy controls.
Keywords
- anti-synthetase syndrome (ASS)
- single-cell RNA sequencing (scRNA-seq)
- mucosal-associated invariant T (MAIT) cell
- IFN-II
- auto-immune diseases